91 related articles for article (PubMed ID: 3098341)
1. Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.
Selby PL; Peacock M
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1337-9. PubMed ID: 3098341
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women.
Selby P; McGarrigle HH; Peacock M
Clin Endocrinol (Oxf); 1989 Mar; 30(3):241-9. PubMed ID: 2512035
[TBL] [Abstract][Full Text] [Related]
3. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
Sipinen S
Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
[TBL] [Abstract][Full Text] [Related]
4. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.
Selby PL; Peacock M
Clin Endocrinol (Oxf); 1986 Nov; 25(5):543-7. PubMed ID: 3113780
[TBL] [Abstract][Full Text] [Related]
5. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
6. Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.
Stevenson JC; Shennan NM; Whitehead MI
Br Med J (Clin Res Ed); 1987 Jan; 294(6565):181. PubMed ID: 3109564
[No Abstract] [Full Text] [Related]
7. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
Maffei S; Del Ry S; Prontera C; Clerico A
Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy by transdermal estradiol administration.
Laufer LR; DeFazio JL; Lu JK; Meldrum DR; Eggena P; Sambhi MP; Hershman JM; Judd HL
Am J Obstet Gynecol; 1983 Jul; 146(5):533-40. PubMed ID: 6407324
[TBL] [Abstract][Full Text] [Related]
9. [Oral or transdermal estrogen substitution therapy in climacteric?].
Runnebaum B; Salbach B; von Holst T
Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):119-30. PubMed ID: 8188009
[TBL] [Abstract][Full Text] [Related]
10. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
[TBL] [Abstract][Full Text] [Related]
11. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
Farish E; Barnes JF; Rankin M; Hart DM
Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
Panay N; Versi E; Savvas M
BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
[TBL] [Abstract][Full Text] [Related]
13. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Br J Obstet Gynaecol; 1983 Apr; 90(4):355-60. PubMed ID: 6682335
[TBL] [Abstract][Full Text] [Related]
14. [Climacteric syndrome].
Imthurn B; Maurer-Major E
Ther Umsch; 2000 Oct; 57(10):595-9. PubMed ID: 11081369
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapy.
Nilsson B; Holst J; von Schoultz B
Br J Obstet Gynaecol; 1984 Oct; 91(10):1031-6. PubMed ID: 6541503
[TBL] [Abstract][Full Text] [Related]
16. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
17. Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol.
Matsui S; Yasui T; Kasai K; Keyama K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
J Obstet Gynaecol; 2017 Jul; 37(5):627-632. PubMed ID: 28317410
[TBL] [Abstract][Full Text] [Related]
18. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
19. Oestradiol treatment helped a depressed postmenopausal woman to stop her psychotropic medication: a case report.
Korhonen S; Saarijärvi S
Acta Psychiatr Scand; 1996 Dec; 94(6):480-1. PubMed ID: 9021004
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
Arrenbrecht S; Boermans AJ
Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
